Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

Status: Recruiting
Location: See location...
Intervention Type: Procedure, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are: What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 20
Healthy Volunteers: f
View:

• Patients with acute cerebrovascular disease, within 1 month after acute attack.

• Stable medical condition: (1). Neurological condition: The neurological condition has not deteriorated for more than 72 hours. (2). Vital signs including blood pressure, heartbeat, and body temperature are stable or controllable for more than 72 hours. (3). No complications such as infection, blood abnormalities, gastrointestinal bleeding, or stable or controllable after treatment.

• Those whose functional status is moderate to moderately severe functional impairment (MRS 3-4) and who are judged by the medical team to have active rehabilitation potential: (1). Have basic cognition, learning ability and willingness. (2) Have sufficient physical strength: able to maintain a sitting position on a wheelchair or bed edge for at least one hour with support. (3). Be able to actively participate in rehabilitation treatment plans.

• Aged over 20 years old

Locations
Other Locations
Taiwan
China Medical University Hospital Taichung East District Branch
RECRUITING
Taichung
Contact Information
Primary
Li-Wei Chou, PhD
chouliwe@gmail.com
886+975681612
Time Frame
Start Date: 2024-10-22
Estimated Completion Date: 2025-05-15
Participants
Target number of participants: 110
Treatments
Experimental: EECP+PAC
Patients receive 35 times EECP treatments during standard PAC program.
Active_comparator: PAC
Patients receive standard PAC program.
Related Therapeutic Areas
Sponsors
Leads: China Medical University Hospital

This content was sourced from clinicaltrials.gov